Kimia Farma Persero Tbk (KAEF) - Total Liabilities
Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has total liabilities worth Rp11.91 Trillion IDR (≈ $697.78 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore KAEF strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Kimia Farma Persero Tbk - Total Liabilities Trend (2002–2025)
This chart illustrates how Kimia Farma Persero Tbk's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Kimia Farma Persero Tbk (KAEF) total assets.
Kimia Farma Persero Tbk Competitors by Total Liabilities
The table below lists competitors of Kimia Farma Persero Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kizilbuk Gayrimenkul Yatirim Ortakligi AS
IS:KZBGY
|
Turkey | TL10.62 Billion |
|
ABC Taiwan Electronics
TWO:3236
|
Taiwan | NT$1.50 Billion |
|
GAMCO Natural Resources Gold and Income Closed Fund
NYSE:GNT
|
USA | $10.58 Million |
|
Duksan Hi Metal Co.Ltd
KQ:077360
|
Korea | ₩320.20 Billion |
|
Manaksia Coated Metals & Industries Limited
NSE:MANAKCOAT
|
India | Rs4.06 Billion |
|
Quirin Privatbank AG
F:QB7
|
Germany | €1.34 Billion |
|
Garda Property Group
AU:GDF
|
Australia | AU$170.84 Million |
|
Bisalloy Steel Group Ltd
AU:BIS
|
Australia | AU$39.64 Million |
Liability Composition Analysis (2002–2025)
This chart breaks down Kimia Farma Persero Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Kimia Farma Persero Tbk (KAEF) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.81 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kimia Farma Persero Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kimia Farma Persero Tbk (2002–2025)
The table below shows the annual total liabilities of Kimia Farma Persero Tbk from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Rp11.67 Trillion ≈ $684.01 Million |
+1.17% |
| 2024-12-31 | Rp11.54 Trillion ≈ $676.09 Million |
+3.09% |
| 2023-12-31 | Rp11.19 Trillion ≈ $655.84 Million |
+1.62% |
| 2022-12-31 | Rp11.01 Trillion ≈ $645.42 Million |
+4.62% |
| 2021-12-31 | Rp10.53 Trillion ≈ $616.92 Million |
+0.68% |
| 2020-12-31 | Rp10.46 Trillion ≈ $612.75 Million |
-4.41% |
| 2019-12-31 | Rp10.94 Trillion ≈ $641.04 Million |
+79.23% |
| 2018-12-31 | Rp6.10 Trillion ≈ $357.67 Million |
+73.23% |
| 2017-12-31 | Rp3.52 Trillion ≈ $206.47 Million |
+50.51% |
| 2016-12-31 | Rp2.34 Trillion ≈ $137.18 Million |
+70.37% |
| 2015-12-31 | Rp1.37 Trillion ≈ $80.52 Million |
+18.76% |
| 2014-12-31 | Rp1.16 Trillion ≈ $67.80 Million |
+36.51% |
| 2013-12-31 | Rp847.58 Billion ≈ $49.67 Million |
+33.52% |
| 2012-12-31 | Rp634.81 Billion ≈ $37.20 Million |
+17.18% |
| 2011-12-31 | Rp541.74 Billion ≈ $31.74 Million |
-0.28% |
| 2010-12-31 | Rp543.26 Billion ≈ $31.83 Million |
-4.24% |
| 2009-12-31 | Rp567.31 Billion ≈ $33.24 Million |
+13.94% |
| 2008-12-31 | Rp497.91 Billion ≈ $29.18 Million |
+4.01% |
| 2007-12-31 | Rp478.71 Billion ≈ $28.05 Million |
+22.57% |
| 2006-12-31 | Rp390.57 Billion ≈ $22.89 Million |
+17.15% |
| 2005-12-31 | Rp333.38 Billion ≈ $19.53 Million |
-7.10% |
| 2004-12-31 | Rp358.85 Billion ≈ $21.03 Million |
-41.39% |
| 2003-12-31 | Rp612.31 Billion ≈ $35.88 Million |
+69.50% |
| 2002-12-31 | Rp361.25 Billion ≈ $21.17 Million |
-- |
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrup… Read more